Logo De Société De Biotechnologie De Biogen Image éditorial - Image du médecines, hématologique: 102563960
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
Samsung Group reportedly in talks to acquire Biogen < Pharma < Article - KBR
Samsung intéressé par le rachat du laboratoire Biogen | La Presse
Samsung Bioepis seeks to buy Biogen biosimilar unit - KED Global
Samsung Biologics Buys Bioepis Stake for $2.3 Billion From Biogen - Bloomberg
Biogen and Samsung Bioepis present data for Infliximab and Adalimumab biosimilars - Hub Publishing
Samsung s'associe à Biogen Idec
Samsung Bioepis conclut un nouvel accord de commercialisation avec Biogen
Samsung Biologics buys out Biogen in biosim venture for US$2.3B | HealthCare Middle East & Africa Magazine
Samsung Biologics Prepares for Budding Alzheimer's Treatment Deals
Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn
Company News | Newsroom | SAMSUNG BIOLOGICS
Samsung Biologics to acquire Biogen's stake in Samsung Bioepis
Biosimilaires: Samsung Bioepis se renforce sur un marché porteur - actualités- Pharmaceutiques
Samsung Bioepis ponders acquiring unit from U.S. partner Biogen
Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million | BioSpace
Biogen of US might reap W2tr from Samsung Bioepis call option
Samsung in talks to acquire Biogen, per report - The Boston Globe
Samsung intéressé par le rachat du laboratoire Biogen pour plus de $40 milliards | Arab News FR
Biosimilaires : Samsung Bioepis conclut un nouvel accord de commercialisation avec Biogen | MyPharma Editions
Biogen gains ophthalmology biosimilar candidates for Lucentis, Eylea in deal with Samsung Bioepis
Samsung Bioepis : ventes record en Europe au T1 | AGENCE DE PRESSE YONHAP
Biogen Poised for Pipeline Growth, Samsung Eyes New Drug Expansion after $2.3B Joint Venture Deal
